Cloud-based platform integrates operations in the United States and Canada.
After joining forces in April of this year, Chesapeake IRB and IRB Services, both North American leaders in providing central ethical review services, began making plans to integrate submission processes in the United States and Canada utilizing a common, powerful, proven, electronic platform, CIRBI.
We are pleased to announce that the integration is now complete.
Center for IRB Intelligence (CIRBI™)
Chesapeake IRB's revolutionary platform, the Center for IRB Intelligence (CIRBI), provides cloud-based access to an entire ethics review project. The fully integrated system unifies all Chesapeake IRB and IRB Services functions under one easy-to-use platform.
CIRBI, which already has thousands of sponsors and investigators on board, provides revolutionary capabilities for accelerating cycle time and proactive project management. It is a powerful, elegant, efficient and trusted tool.
Progressive, Creative, Transformative
Jeff Wendel, President of Chesapeake IRB, said the decision to offer CIRBI in the US and Canada represents the progressive, creative approach to problem-solving that characterizes both companies.
"Our decision to integrate CIRBI was driven by our desire to provide North American clients with the benefit of one-click access to study information."
Jack Corman, Founder and Managing Director of IRB Services, calls CIRBI a truly transformative study management tool.
"CIRBI is the only electronic clinical project management platform that's genuinely seamless - gives both clients and sites a fully transparent, uniquely empowering experience to drive efficiencies as never before."
About Chesapeake IRB
Chesapeake IRB has been providing independent IRB services for major pharmaceutical companies, universities, individual researchers, academic medical centers, and community hospitals since 1993.
Chesapeake IRB earned AAHRPP accreditation in 2004 and was accredited for a third time in June 2010.
Chesapeake IRB offers a unique 21 CFR Part 11 compliant, electronic IRB platform (CIRBI) which streamlines protocol submissions and decreases investigator review turnaround times resulting in faster subject enrollments.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Tirzepatide Demonstrates Superior Weight Loss to Semaglutide in 72-Week Phase IIIb SURMOUNT-5 Trial
May 12th 2025In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist tirzepatide (Zepbound) delivered significantly greater and sustained weight loss than semaglutide (Wegovy) over 72 weeks in adults with obesity or overweight and comorbidities.